drugset / Trial / NCT02275611

Oxytocin Treatment of Alcohol Dependence

NCT02275611

Phase 2 Completed 13 enrolled University of North Carolina, Chapel Hill
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study will test in individuals who have alcohol dependence (alcohol addiction) the hypotheses 1) that intranasal oxytocin treatment will decrease withdrawal symptoms during medical detoxification and 2) that intranasal oxytocin treatment for 12 weeks in the outpatient setting will decrease drinking.

Timeline

Start
2013-01
Primary completion
2013-12
Completion
2014-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Oxytocin Peptide 0.6 ml Intranasal